Abstract: The invention provides methods and materials for screening for polymorphic variants in ABCB1 and diagnosing altered susceptibilities for drug-induced heart rhythm irregularities based on the same. These methods allow better treatment regimens for using drugs that bind a protein encoded by the ABCB1 and/or induce heart rhythm irregularities such as the anti-cancer drug FK228.
Type:
Application
Filed:
November 9, 2006
Publication date:
December 31, 2009
Applicant:
Government of the United States of America, as Represented by Secretary, Dept. of Human Services
Inventors:
William D. Figg, Alexander Sparreboom, Tristan Sissung, Richard L. Piekarz, Susan E. Bates